LONDON BROKER RATINGS: Diageo gets price target cuts; JPMorgan ups M&G
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:
Read moreFri, 27th Nov 2020 13:18
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:
Read more(Sharecast News) - London's stock markets were buoyant at the close of trading on Thursday, influenced by Chinese inflation data, a substantial influx of corporate news, and a speech from the Fed chair later in the global day.
Read more(Alliance News) - European equities were on the up on Thursday, despite lingering US interest rate worries and poor China data.
Read more(Alliance News) - Lancashire Holdings Ltd on Thursday said it approved a capital return of up to USD169 million, and it reported rising gross premiums written for the year-to-date.
Read more(Alliance News) - AstraZeneca PLC on Thursday announced that it signed a contract for an obesity drug as it reported a higher pretax profit in the third quarter of 2023, boosted by cancer drug conjugate Enhertu.
Read more(Alliance News) - London's FTSE 100 struggled for direction early Thursday, with a mixed slate of corporate updates, US interest rate worries and underwhelming China data preventing it from making more confident progress in early trade.
Read more(Alliance News) - London's FTSE 100 is set for another downbeat start to the day, with more hawkish comments from US central bankers and tepid data out of China doing little to lift the mood.
Read more(Sharecast News) - AstraZeneca released its financial results for the third quarter and first nine months of 2023 on Thursday, hiking its full-year guidance on the back of a robust performance and momentum in several segments.
Read more(Alliance News) - AstraZeneca PLC on Friday touted results from a Phase IIb trial, which showed that a zibotentan and dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria.
Read more(Alliance News) - AstraZeneca PLC on Thursday celebrated results from an observational study, which showed that treating hyperkalaemia with the potassium binder, Lokelma, allows chronic kidney disease and heart failure patients to maintain RAASi therapy.
Read moreFriday 3 November | |
no events scheduled | |
Monday 6 November | |
Kingspan Group PLC | Trading Statement |
Kosmos Energy Ltd | Q3 Results |
Ryanair Holdings PLC | Half Year Results |
Tuesday 7 November | |
Associated British Foods PLC | Full Year Results |
Beazley PLC | Q3 Results |
Direct Line Insurance Group PLC | Trading Statement |
dotdigital Group PLC | Full Year Results |
IWG PLC | Q3 Results |
Persimmon PLC | Trading Statement |
RS Group PLC | Half Year Results |
Vaalco Energy Inc | Q3 Results |
Watches of Switzerland Group PLC | Trading Statement |
Wednesday 8 November | |
Conduit Holdings Ltd | Q3 Results |
ITV PLC | Trading Statement |
JD Wetherspoon PLC | Q1 Results |
Marks & Spencer Group PLC | Half Year Results |
MaxCyte Inc | Q3 Results |
Secure Trust Bank PLC | Trading Statement |
Smiths News PLC | Full Year Results |
Time Out Group PLC | Full Year Results |
Thursday 9 November | |
3i Group PLC | Half Year Results |
Apax Global Alpha Ltd | Q3 Results |
AstraZeneca PLC | Q3 Results |
Auto Trader Group PLC | Half Year Results |
B&M European Value Retail SA | Half Year Results |
Domino's Pizza Group PLC | Trading Statement |
Endeavour Mining PLC | Q3 Results |
Flutter Entertainment PLC | Trading Statement |
IMI PLC | Trading Statement |
Indivior PLC | Q3 Results |
John Wood Group PLC | Trading Statement |
Lancashire Holdings Ltd | Trading Statement |
National Grid PLC | Half Year Results |
Regional REIT Ltd | Trading Statement |
Renewi PLC | Half Year Results |
S4 Capital PLC | Trading Statement |
Tate & Lyle PLC | Half Year Results |
Taylor Wimpey PLC | Trading Statement |
TBC Bank Group PLC | Q3 Results |
TheWorks.co.uk PLC | Trading Statement |
Trakm8 Holdings PLC | Half Year Results |
Urban Logistics REIT PLC | Half Year Results |
Vistry Group PLC | Trading Statement |
WH Smith PLC | Full Year Results |
Wincanton PLC | Half Year Results |
Wizz Air Holdings PLC | Half Year Results |
Copyright 2023 Alliance News Ltd. All Rights Reserved. |
(Alliance News) - AstraZeneca PLC on Wednesday announced a new collaboration and investment agreement with clinical-stage biotechnology company Cellectis.
Read more(Sharecast News) - AstraZeneca is to invest in French biopharma group Cellectis to use its gene-editing technologies to develop next-gen therapeutics in areas like oncology, immunology and rare diseases.
Read more(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
Read more(Alliance News) - Pascal Soriot has committed to remaining as chief executive officer of AstraZeneca PLC for another five years, The Times reported on Wednesday.
Read more